Suppr超能文献

基于链置换和末端脱氧核苷酸转移酶辅助扩增策略的无标记miRNA-21分析

Label-Free miRNA-21 Analysis Based on Strand Displacement and Terminal Deoxynucleotidyl Transferase-Assisted Amplification Strategy.

作者信息

Yan Ying, Zhao Han, Fang Yukang, Ma Changbei, Chen Junxiang

机构信息

School of Life Sciences, Central South University, Changsha 410013, China.

Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.

出版信息

Biosensors (Basel). 2022 May 12;12(5):328. doi: 10.3390/bios12050328.

Abstract

MicroRNAs (miRNAs) are regarded as a rising star in the biomedical industry. By monitoring slight increases in miRNA-21 levels, the possibilities of multi-type malignancy can be evaluated more precisely and earlier. However, the inconvenience and insensitivity of traditional methods for detecting miRNA-21 levels remains challenging. In this study, a partially complementary cDNA probe was designed to detect miRNA-21 with target-triggered dual amplification based on strand displacement amplification (SDA) and terminal deoxynucleotidyl transferase (TdT)-assisted amplification. In this system, the presence of miRNA-21 can hybridize with template DNA to initiate SDA, generating a large number of trigger molecules. With the assistance of TdT and dGTP, the released trigger DNA with 3'-OH terminal can be elongated to a superlong poly(guanine) sequence, and a notable fluorescence signal was observed in the presence of thioflavin T. By means of dual amplification strategy, the sensing platform showed a good response tomiRNA-21 with a detection limit of 1.7 pM (S/N = 3). Moreover, the specificity of this method was verified using a set of miRNA with sequence homologous to miRNA-21. In order to further explore its practical application capabilities, the expression of miRNA in different cell lines was quantitatively analyzed and compared with the qRT-PCR. The considerable results of this study suggest great potential for the application of the proposed approach in clinical diagnosis.

摘要

微小RNA(miRNA)被视为生物医学领域的一颗新星。通过监测miRNA - 21水平的微小升高,可以更精确、更早期地评估多种恶性肿瘤的可能性。然而,传统检测miRNA - 21水平方法的不便性和不敏感性仍然具有挑战性。在本研究中,设计了一种部分互补的cDNA探针,基于链置换扩增(SDA)和末端脱氧核苷酸转移酶(TdT)辅助扩增,通过靶标触发的双重扩增来检测miRNA - 21。在该系统中,miRNA - 21的存在可与模板DNA杂交以启动SDA,产生大量触发分子。在TdT和dGTP的辅助下,具有3'-OH末端的释放触发DNA可延伸为超长聚鸟嘌呤序列,并且在硫黄素T存在下观察到显著的荧光信号。通过双重扩增策略,传感平台对miRNA - 21表现出良好的响应,检测限为1.7 pM(S/N = 3)。此外,使用一组与miRNA - 21序列同源的miRNA验证了该方法的特异性。为了进一步探索其实际应用能力,对不同细胞系中miRNA的表达进行了定量分析,并与qRT-PCR进行了比较。本研究的可观结果表明所提出的方法在临床诊断中的应用具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/416a/9138311/7973f268513d/biosensors-12-00328-sch001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验